Found 10 matching trials
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects PHASE2 To evaluate the antibody response to each influenza vaccine antigen when ad...
Show More Location
Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio
Learn More & Join Trial
A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine PHASE2 This study is designed to generate clinical data as outlined in the Note fo...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects PHASE2 To evaluate the antibody response to each influenza vaccine antigen when ad...
Show More Location
Dipartimento di Medicina e Scienze dell'Invecchiamento
Learn More & Join Trial
Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008 PHASE2 Due to antigenic changes of influenza viruses, the virus strains used in in...
Show More Location
The Health Centre
Learn More & Join Trial
Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases. PHASE2 This phase II, open label, is designed as a seasonal study to support annua...
Show More Location
Azienda Sanitaria USL 7 di Siena
Learn More & Join Trial
Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over PHASE2 This observer blind study is designed to compare the immune response of GSK...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects PHASE2 Primary Objective:
To describe the immune response to a single administrat...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial to Describe the Safety and Immunogenicity of Fluzone® PHASE2 Objective 1:To describe the safety of the inactivated, split-virion influen...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine PHASE4 To provide Centers for Biologic Evaluation and Research (CBER) with sera co...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV PHASE3 The purpose of this study was to evaluate and compare the safety, reactogen...
Show More Location
Kaiser Permanente Pediatric Clinic - Fresno
Learn More & Join Trial